Expanding offering for Multiple Myeloma and AL Amyloidosis Testing.
News & Stories
Results
Sebia acquires Orgentec Diagnostika, strengthening its product portfolio and strategy in autoimmunity and expanding its diagnostic solutions.
Expanding offering for Multiple Myeloma and AL Amyloidosis Testing.
Sebia acquires Orgentec Diagnostika, strengthening its product portfolio and strategy in autoimmunity and expanding its diagnostic solutions.